Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival

Women With Malignant Pleural Mesothelioma Have a Threefold Better Survival Rate Than Men

(2014) Emanuela Taioli et al.   ANNALS OF THORACIC SURGERY

Germline Mutation of Bap1 Accelerates Development of Asbestos-Induced Malignant Mesothelioma

(2014) J. Xu et al.   CANCER RESEARCH

Germline Mutations in BAP1 Impair Its Function in DNA Double-Strand Break Repair

(2014) I. H. Ismail et al.   CANCER RESEARCH

Germline BAP1 Mutations Predispose to Renal Cell Carcinomas

(2013) Tatiana Popova et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation

(2013) C. Ribeiro et al.   ANNALS OF ONCOLOGY

The Worldwide Pandemic of Asbestos-Related Diseases

(2013) Leslie Stayner et al.   Annual Review of Public Health

BAP1germline mutation in two first grade family members with uveal melanoma

(2013) David A Maerker et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma

(2013) Richard W. Joseph et al.   CANCER

Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: A Report by MSKCC and the KIRC TCGA Research Network

(2013) A. A. Hakimi et al.   CLINICAL CANCER RESEARCH

Hereditary uveal melanoma: A report of a germline mutation inBAP1

(2013) Veronica Höiom et al.   GENES CHROMOSOMES & CANCER

Expanding the clinical phenotype of hereditaryBAP1cancer predisposition syndrome, reporting three new cases

(2013) Robert Pilarski et al.   GENES CHROMOSOMES & CANCER

Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003–2008

(2013) S Jane Henley et al.   INTERNATIONAL JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH

Clinical Characteristics of Patients with Malignant Pleural Mesothelioma Harboring Somatic BAP1 Mutations

(2013) Marjorie G. Zauderer et al.   Journal of Thoracic Oncology

BAP1 Immunohistochemistry Predicts Outcomes in a Multi-Institutional Cohort with Clear Cell Renal Cell Carcinoma

(2013) Payal Kapur et al.   JOURNAL OF UROLOGY

Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation

(2013) Payal Kapur et al.   LANCET ONCOLOGY

Mesothelioma: closer to the target?

(2013) Harvey I Pass   LANCET ONCOLOGY

Asbestos is not just asbestos: an unrecognised health hazard

(2013) Francine Baumann et al.   LANCET ONCOLOGY

A Novel Germline Mutation in BAP1 Predisposes to Familial Clear-Cell Renal Cell Carcinoma

(2013) M. N. Farley et al.   MOLECULAR CANCER RESEARCH

A BAP1 Mutation in a Danish Family Predisposes to Uveal Melanoma and Other Cancers

(2013) Lauren G. Aoude et al.   PLoS One

Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma

(2013) Mitchell Cheung et al.   Cancer Genetics

Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma

(2012) Yoshie Yoshikawa et al.   CANCER SCIENCE

The ticking time-bomb of asbestos: Its insidious role in the development of malignant mesothelioma

(2012) Anthony Linton et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Toward an Improved Definition of the Tumor Spectrum Associated WithBAP1Germline Mutations

(2012) Thomas Wiesner et al.   JOURNAL OF CLINICAL ONCOLOGY

BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs

(2012) Michele Carbone et al.   Journal of Translational Medicine

Prevalence of germlineBAP1mutation in a population-based sample of uveal melanoma cases

(2012) Lauren G. Aoude et al.   Pigment Cell & Melanoma Research

A crypticBAP1splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma

(2012) Karin Wadt et al.   Pigment Cell & Melanoma Research

Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families

(2012) Ching-Ni Jenny Njauw et al.   PLoS One

Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008

(2011) Vanya Delgermaa et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Malignant mesothelioma: Facts, Myths, and Hypotheses

(2011) Michele Carbone et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers

(2011) M. H. Abdel-Rahman et al.   JOURNAL OF MEDICAL GENETICS

Germline BAP1 mutations and tumor susceptibility

(2011) Alisa M Goldstein   NATURE GENETICS

Germline mutations in BAP1 predispose to melanocytic tumors

(2011) Thomas Wiesner et al.   NATURE GENETICS

Germline BAP1 mutations predispose to malignant mesothelioma

(2011) Joseph R Testa et al.   NATURE GENETICS

Frequency of Use and Predictors of Cancer-Directed Surgery in the Management of Malignant Pleural Mesothelioma in a Community-Based (Surveillance, Epidemiology, and End Results [SEER]) Population

(2010) Raja M. Flores et al.   Journal of Thoracic Oncology

Malignant Pleural Mesothelioma: A Population-Based Study of Survival

(2010) Michael T. Milano et al.   Journal of Thoracic Oncology

Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas

(2010) J. W. Harbour et al.   SCIENCE

Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973–2005

(2009) Suresh H. Moolgavkar et al.   CANCER CAUSES & CONTROL

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience

(2009) Tristan D. Yan et al.   JOURNAL OF CLINICAL ONCOLOGY